Studies have revealed that targeting T cell-exhaustion-related proteins like BATF, IKZF2, and TLE4 can significantly increase the persistence and anti-tumor capabilities of CAR-T cells both in vitro and in vivo32. Here, BATF is linked to neoplasm.